LONDON (Reuters) – The first patient has been treated in Britain in a pioneering trial of a new treatment co-developed by Pfizer and derived from embryonic stem cells designed for patients with a condition that can cause blindness. Specialists at London’s Moorfields Eye Hospital said the operation, described as “successful”, was the first of 10 […]
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
